Cambium Networks (CMBM) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
7 Apr, 2026Executive summary
Revenue for 2024 was $177.3 million, down 21.8% year-over-year, with a net loss of $74.5 million, similar to 2023's net loss of $74.1 million.
The company restated prior financials due to material weaknesses in internal controls, impacting revenue recognition, inventory, credit losses, and impairments.
Substantial doubt exists about the company's ability to continue as a going concern due to ongoing credit agreement defaults and liquidity issues.
Shares were delisted from Nasdaq in March 2026 and now trade on the OTC Expert Market.
Financial highlights
Product revenue fell 24.2% to $157.8 million; subscriptions and services revenue rose 4.6% to $19.5 million.
Gross margin improved to 35.5% from 33.9% year-over-year, driven by lower excess/obsolete inventory and supplier commitment expenses.
Operating expenses decreased 2.1% to $133.3 million, with significant reductions in R&D, sales/marketing, and G&A.
Impairment charges of $25.5 million were recorded in 2024 for goodwill, intangibles, and long-lived assets.
Interest expense more than doubled to $5.8 million due to increased borrowings and higher rates.
Cash balance at year-end was $34.9 million, up from $18.7 million, but all credit facility availability was exhausted.
Outlook and guidance
Management expects continued revenue and margin pressure due to weak demand, aggressive competition, and macroeconomic uncertainty.
The company is actively seeking additional capital, considering divestitures, and negotiating with lenders to address liquidity and covenant defaults.
No guidance provided for 2025 due to ongoing uncertainty and inability to forecast customer demand.
Latest events from Cambium Networks
- Virtual meeting to vote on directors, auditor, compensation, and reverse share split; board supports all.CMBM
Proxy filing12 May 2026 - Q3 2025 revenue fell 3.7% year-over-year, with a net loss of $8.5 million and ongoing debt defaults.CMBM
Q3 202530 Apr 2026 - Revenue fell 12.9% year-over-year as liquidity and covenant risks threaten ongoing operations.CMBM
Q2 202530 Apr 2026 - Q2 revenue up 9% sequentially, but down 23% year-over-year, with margin and cash flow gains.CMBM
Q2 20242 Feb 2026 - Revenue and margins improved, but debt covenant breaches threaten financial stability.CMBM
Q3 202415 Jan 2026